fashion -WSS

fashion

author：Wikipedia 2025-09-30 22:03:58 - browse：27

Hyacinth Empinado/STAT

The body mass index, or BMI, is the formula that’s used most often to diagnose overweight and obesity. But unlike other common diagnoses, there is a certain stigma applied to people with a high body mass index, or BMI, which can affect how they are perceived by peers, providers, and society at large.

Despite the ubiquity of the BMI in medicine, many argue that it is a flawed tool, with a strange history. In recent months, the BMI has become more relevant than ever as the new semaglutide weight loss drugs are poised to change how obesity is understood and treated.

BMI is a simple calculation — a person’s weight in kilograms divided by the square of their height. But how BMI is then translated into a diagnosis is complicated and flawed.

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Watch this video to learn more about the history of the BMI — how it became so entrenched in medicine and, surprisingly, how its introduction may have set back decades of work on how obesity contributes to disease.

A STAT series is examining new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution.

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Decaf coffee targeted by food safety group under obscure FDA rule

WSS

Readout Newsletter: Merck, Vertex, and Viking updates

Covid vaccine financial winners and losers, from Pfizer to Novavax

How to bring more disabled researchers into academia

Eliminate the waiting period for sterilization covered by Medicaid

Novo Nordisk obesity pill bests Wegovy in early trial

Novo Nordisk obesity pill bests Wegovy in early trial

focus

fashion

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Guidelines to prevent youth baseball injuries need more muscle

Oprah kicked off a national conversation on obesity. Let's have it

Trump demands the U.S. pay no more for drugs than other countries … again

Patient advocates debate FDA's accelerated approval process

Medical leaders decry Supreme Court decision on affirmative action

Eliminate the waiting period for sterilization covered by Medicaid

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: Merck, Vertex, and Viking updates

hotspot

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

With psoriasis trial ahead, Alumis raises $259 million

CDC marks new Covid

Readout Newsletter: Merck, Vertex, and Viking updates

Food as medicine: Medically tailored meals may get standardized

Supreme Court mifepristone arguments center on docs' right to sue

hotspot

hotspot

knowledge

focus